Recurrence of borderline ovarian tumors

Recurrence of borderline ovarian tumors

Aim - to increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age - 38,9 +- 5,5 years), who were treated with standard surgical op...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2013
Автори: Svintsitskiy, V.S., Vorobyova, L.I., Klymenko, E.S., Dermenzhy, T.V., Tkalya, J.G.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Назва видання:Experimental Oncology
Теми:
Original contributions
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/145204
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Recurrence of borderline ovarian tumors / V.S. Svintsitskiy, L.I. Vorobyova, E.S. Klymenko, T.V. Dermenzhy, J.G. Tkalya // Experimental Oncology. — 2013. — Т. 35, № 2. — С. 118-121. — Бібліогр.: 17 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-145204
record_format dspace
spelling irk-123456789-1452042019-01-21T01:23:01Z Recurrence of borderline ovarian tumors Svintsitskiy, V.S. Vorobyova, L.I. Klymenko, E.S. Dermenzhy, T.V. Tkalya, J.G. Original contributions Aim - to increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age - 38,9 +- 5,5 years), who were treated with standard surgical operation (panhysterectomy); the II group (24 patients, mean age - 30,3 +- 5,5 years), who underwent preserving surgery. The main method of treatment of patients with BOT is surgical. For patients of older age effective extension is panhysterectomy with the greater omentum resection. Further chemotherapy can be applied as the second stage of complex treatment in case of confounding factor of prognosis. Preserving treatment does not aggravate the indices of the survival rate among patients with BOT, which is confirmed by results of 5- and 10-years survival rate among patients after the preserving (I group) and standard surgery (II group): 87,4 and 79,2 % in the I group respectively, and 80,1 and 72,3 % in the II group respectively. The frequency of recurrence is higher in cases of bilateral affection of ovaries (IB stage), collapse of a capsule prior to the surgery. Sonography is a highly informative method of diagnostics of BOT relapse with its sensitivity 83,5 %, specifity - 64 %, favorable prognostic possibility - 56 %, unfavorable prognostic possibility - 66,4 %. 2013 Article Recurrence of borderline ovarian tumors / V.S. Svintsitskiy, L.I. Vorobyova, E.S. Klymenko, T.V. Dermenzhy, J.G. Tkalya // Experimental Oncology. — 2013. — Т. 35, № 2. — С. 118-121. — Бібліогр.: 17 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/145204 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Svintsitskiy, V.S.
Vorobyova, L.I.
Klymenko, E.S.
Dermenzhy, T.V.
Tkalya, J.G.
Recurrence of borderline ovarian tumors
Experimental Oncology
description Aim - to increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age - 38,9 +- 5,5 years), who were treated with standard surgical operation (panhysterectomy); the II group (24 patients, mean age - 30,3 +- 5,5 years), who underwent preserving surgery. The main method of treatment of patients with BOT is surgical. For patients of older age effective extension is panhysterectomy with the greater omentum resection. Further chemotherapy can be applied as the second stage of complex treatment in case of confounding factor of prognosis. Preserving treatment does not aggravate the indices of the survival rate among patients with BOT, which is confirmed by results of 5- and 10-years survival rate among patients after the preserving (I group) and standard surgery (II group): 87,4 and 79,2 % in the I group respectively, and 80,1 and 72,3 % in the II group respectively. The frequency of recurrence is higher in cases of bilateral affection of ovaries (IB stage), collapse of a capsule prior to the surgery. Sonography is a highly informative method of diagnostics of BOT relapse with its sensitivity 83,5 %, specifity - 64 %, favorable prognostic possibility - 56 %, unfavorable prognostic possibility - 66,4 %.
format Article
author Svintsitskiy, V.S.
Vorobyova, L.I.
Klymenko, E.S.
Dermenzhy, T.V.
Tkalya, J.G.
author_facet Svintsitskiy, V.S.
Vorobyova, L.I.
Klymenko, E.S.
Dermenzhy, T.V.
Tkalya, J.G.
author_sort Svintsitskiy, V.S.
title Recurrence of borderline ovarian tumors
title_short Recurrence of borderline ovarian tumors
title_full Recurrence of borderline ovarian tumors
title_fullStr Recurrence of borderline ovarian tumors
title_full_unstemmed Recurrence of borderline ovarian tumors
title_sort recurrence of borderline ovarian tumors
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2013
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/145204
citation_txt Recurrence of borderline ovarian tumors / V.S. Svintsitskiy, L.I. Vorobyova, E.S. Klymenko, T.V. Dermenzhy, J.G. Tkalya // Experimental Oncology. — 2013. — Т. 35, № 2. — С. 118-121. — Бібліогр.: 17 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT svintsitskiyvs recurrenceofborderlineovariantumors
AT vorobyovali recurrenceofborderlineovariantumors
AT klymenkoes recurrenceofborderlineovariantumors
AT dermenzhytv recurrenceofborderlineovariantumors
AT tkalyajg recurrenceofborderlineovariantumors
first_indexed 2023-05-20T17:21:30Z
last_indexed 2023-05-20T17:21:30Z
_version_ 1796153114847346688

Схожі ресурси